Read More 1 minute read Analyst Ratings News Price Target Deutsche Bank Maintains Hold on PlayAGS, Lowers Price Target to $11 By Benzinga Newsdesk July 14, 8:19 AM Deutsche Bank analyst Carlo Santarelli maintains PlayAGS (NYSE:AGS) with a Hold and lowers the price target from $12 to $11. AGS
Read More 1 minute read Analyst Ratings News Price Target Deutsche Bank Maintains Buy on Starbucks, Lowers Price Target to $91 By Benzinga Newsdesk July 14, 8:17 AM Deutsche Bank analyst Brian Mullan maintains Starbucks (NASDAQ:SBUX) with a Buy and lowers the price target from $103 to $91. SBUX
Read More 1 minute read Analyst Ratings News Price Target Morgan Stanley Maintains Overweight on Aptiv, Lowers Price Target to $149 By Benzinga Newsdesk July 14, 8:15 AM Morgan Stanley analyst Adam Jonas maintains Aptiv (NYSE:APTV) with a Overweight and lowers the price target from $155 to $149. APTV
Read More 1 minute read Analyst Ratings News Price Target Truist Securities Maintains Buy on Privia Health Group, Raises Price Target to $40 By Benzinga Newsdesk July 14, 8:13 AM Truist Securities analyst David Macdonald maintains Privia Health Group (NASDAQ:PRVA) with a Buy and raises the price target from $36 to $40. PRVA
Read More 1 minute read Analyst Ratings News Price Target Credit Suisse Maintains Outperform on Nasdaq, Lowers Price Target to $189 By Benzinga Newsdesk July 14, 8:11 AM Credit Suisse analyst Gautam Sawant maintains Nasdaq (NASDAQ:NDAQ) with a Outperform and lowers the price target from $221 to $189. NDAQ
Read More 1 minute read Analyst Ratings News Price Target Truist Securities Maintains Buy on Centene, Raises Price Target to $102 By Benzinga Newsdesk July 14, 7:57 AM Truist Securities analyst David Macdonald maintains Centene (NYSE:CNC) with a Buy and raises the price target from $100 to $102. CNC
Read More 1 minute read Analyst Ratings News Price Target Truist Securities Maintains Buy on Amedisys, Lowers Price Target to $150 By Benzinga Newsdesk July 14, 7:52 AM Truist Securities analyst David Macdonald maintains Amedisys (NASDAQ:AMED) with a Buy and lowers the price target from $175 to $150. AMED
Read More 1 minute read Analyst Ratings News Price Target Truist Securities Maintains Buy on AdaptHealth, Raises Price Target to $24 By Benzinga Newsdesk July 14, 7:51 AM Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and raises the price target from $20 to $24. AHCO
Read More 1 minute read Analyst Ratings News Price Target Truist Securities Maintains Buy on Agilon Health, Raises Price Target to $33 By Benzinga Newsdesk July 14, 7:49 AM Truist Securities analyst David Macdonald maintains Agilon Health (NYSE:AGL) with a Buy and raises the price target from $30 to $33. AGL
Read More 1 minute read Analyst Ratings News Price Target Truist Securities Maintains Hold on trivago, Lowers Price Target to $2.3 By Benzinga Newsdesk July 14, 7:46 AM Truist Securities analyst Naved Khan maintains trivago (NASDAQ:TRVG) with a Hold and lowers the price target from $3 to $2.3. TRVG